Public Notice of Intent
Antimicrobial Stewardship, ICS CODE: 11.020.10
Designation Number: HSO 5030
Standards notification on a: New Development
Type of Standard: Intervention
Status: Open for comment (15 days)
Responsible Technical Committee: TC004 – Medication Management
Project Need: The intention in revising this standard is to expand its content, based on client feedback and research, within acute health care organizations. Patient involvement in AMS will also be included in the standard. The Technical Committee acknowledges the need to expand the standards content in the future, to long term care and primary care, in a phased approach.
HSO has decided to convene a standards Technical Committee to revise the current safety intervention standard for Antimicrobial Stewardship HSO 5030:2012
The AMS Safety Intervention Standard provides requirements for organizations to have a comprehensive, evidence-informed antimicrobial stewardship program. The program includes appropriate selection, dosing, route, and duration of antimicrobial therapy. The primary focus of an antimicrobial stewardship program is to optimize antimicrobial use to achieve the best patient outcomes, reduce the risk of infections, reduce or stabilize levels of antibiotic resistance, and promote patient safety.
Developing prescriptive clinical guidelines that specify the details of the AMS program organizations should have, will be out of scope.
This standard is intended for acute health care organizations such as hospitals, in Canada and globally.
Proposed Timeline: April 2018 to February 2020
Posted on: July 18th, 2019
Contact Information: Organizations interested to support the development of this standard or wanting to be consulted as a stakeholder during the development process may contact us at email@example.com. Individuals, including patients, providers, health leaders and the members of the public are encouraged to provide comments through stakeholder organizations.
Click here to return to the full list of notices of intent.